DTE vs EOLS
DTE (DTE) versus Evolus Inc (EOLS) — a side-by-side from cached financials, not a winner call.
DTE (DTE) common stock.
Evolus Inc (EOLS) is a drug manufacturers - specialty & generic company listed on US.
DTE does not have a complete income-statement cache yet.
Latest reported EOLS revenue for 2024-12-31 was $266.3M. Net income was -$50.4M. Revenue was up 31.8% from 2023-12-31 to 2024-12-31. EOLS currently screens at market cap $597.0M.
DTE currently screens at market cap $0. EOLS currently screens at market cap $597.0M.
Not investment advice. Open the DTE and EOLS stock pages for the full models.
Not investment advice.